Pharma-Bio Serv (PBSV) Change in Receivables (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Change in Receivables came in at $77977.0 in Q2 2026, up 224.82% on a YoY basis from $24006.1 in Q2 2025, and down 71.86% quarter-over-quarter from $277116.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Change in Receivables (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Change in Receivables for 17 consecutive years, with $77977.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 224.82% year-over-year to $77977.0; the trailing twelve-month figure through Apr 2026 stood at $27556.0 (up 46.81% YoY), and the FY2025 full-year result was -$203643.0, up 86.02% from the prior year.
- Change in Receivables eased to $77977.0 in Q2 2026 per PBSV's latest filing, from $277116.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $663696.0 in Q2 2023 and bottomed at -$1.6 million in Q1 2024.
- Historically, Change in Receivables has averaged -$65973.1 across 5 years, with a median of $132171.0 in 2025.
- The widest YoY moves for Change in Receivables: up 489.17% in 2025, down 4189.74% in 2025.
- Over 5 years, Change in Receivables stood at -$205939.0 in 2022, then sank by 650.94% to -$1.5 million in 2023, then jumped by 94.22% to -$89380.0 in 2024, then soared by 489.17% to $347839.0 in 2025, then slumped by 77.58% to $77977.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $77977.0, $277116.0, and $347839.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 422.98 Mn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | -24.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | -204.17 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | - |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 36.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 146.32 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | -51.18 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 18.29 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | -79.01 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 77,977.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 77,977.00 |
| Jan 31, 2026 | 277,116.00 |
| Oct 31, 2025 | 347,839.00 |
| Jul 31, 2025 | -675,376.00 |
| Apr 30, 2025 | -62,471.00 |
| Jan 31, 2025 | 186,365.00 |
| Oct 31, 2024 | -89,380.00 |
| Jul 31, 2024 | -15,744.00 |
| Apr 30, 2024 | 209,313.00 |
| Jan 31, 2024 | -1.56 Mn |
| Oct 31, 2023 | -1.55 Mn |
| Jul 31, 2023 | 380,213.00 |
| Apr 30, 2023 | 663,696.00 |
| Jan 31, 2023 | -736,718.00 |
| Oct 31, 2022 | -205,939.00 |
| Jul 31, 2022 | 652,913.00 |
| Apr 30, 2022 | 463,989.00 |
| Jan 31, 2022 | 446,308.00 |
| Oct 31, 2021 | 471,457.00 |
| Jul 31, 2021 | 284,599.00 |